Loading...

Human TruStain FcX™ (Fc Receptor Blocking Solution)

Pricing & Availability
Regulatory Status
RUO
Other Names
Fc Blocker, FcγR blocker, Fc inhibitor
Ave. Rating
Submit a Review
Product Citations
publications
A_Human_TruStain_FcX_031110
Human TruStain FcX™ treated (blue) or non-treated (red) THP-1 cells stained with an irrelevant mouse IgG2a PE mAb (above). Dotted histogram represents unstained cells.
  • A_Human_TruStain_FcX_031110
    Human TruStain FcX™ treated (blue) or non-treated (red) THP-1 cells stained with an irrelevant mouse IgG2a PE mAb (above). Dotted histogram represents unstained cells.
  • A_Human_TruStain_FcX_031110
    Human TruStain FcX™ treated (blue) or non-treated (red) THP-1 cells stained with an irrelevant rat IgG2b PE mAb (above). Dotted histogram represents unstained cells.
  • C_Human_TruStain_FcX_031110
    Human TruStain FcX™ treated (filled histograms) or non-treated (open histograms) THP-1 cells stained with anti-human HLA-DR PE (red) or an isotype control (IgG2a PE, blue) mAbs. Note: non-treated cells show false-negative HLA-DR staining due to high binding of mouse IgG2a isotype.
Cat # Size Price Quantity Check Availability Save
422301 50 tests 81€
Check Availability


Need larger quantities of this item?
Request Bulk Quote
422302 200 tests 184€
Check Availability


Need larger quantities of this item?
Request Bulk Quote
Description

Human Fc receptors (FcRs) are expressed on a variety of cells, such as monocytes, granulocytes, B cells and dendritic cells. The cells with FcR expression sometimes give false positive or false negative results of immunofluorescent staining due to the FcRs-mediated Ig Fc binding. Human TruStain FcX™ is specially formulated for blocking the FcR-involved unwanted staining without interfering with antibody-mediated specific staining of human cells. Human TruStain FcX™ is compatible with flow cytometric staining with anti-human CD16 (clone 3G8), CD32 (clone FUN-2), and CD64 (clone 10.1) antibodies.

Product Details
Technical Data Sheet (pdf)

Product Details

Storage & Handling
Store between 2°C and 8°C.
Application

FC - Quality tested
ICFC, ICC - Reported in the literature, not verified in house
Recommended Usage

It is recommended to add 5 µl of Human TruStain FcX™ per million cells in 100 µl staining volume, mix and incubate at room temperature for 5-10 minutes prior to staining with antibody of interest. It is not necessary to wash cells between these blocking and immunostaining steps.

Application Notes

This buffer contains specialized human IgG in PBS containing 0.09% sodium azide. It is not recommended to be used for staining human IgG. Handle as biohazard agent.

Application References
  1. de la Cruz J, et al. 2011. J. Immunol. 186:2282. PubMed
  2. Luo L, et al. 2011. Exp Mol Pathol. 91:596. PubMed
  3. Szerlip NJ, et al. 2012. PNAS. 109:3041. PubMed
  4. Bromley SK, et al. 2013. J. Immunol. 190:970. PubMed
  5. Trujilo G, et al. 2013. J. Immunol. 191:848. PubMed
  6. Edin S, et al. 2013. PLoS One. 18:74982. PubMed
  7. Euzebio Alves VT, et al. 2013. Infect Immun. 81:4399. PubMed
  8. Borg ZD, et al. 2014. J. Immunol. 192:189. PubMed
  9. Klingenberg R, et al. 2014. Eur Heart J. PubMed
  10. Lines JL, et al. 2014. Cancer Res. 74:1924. PubMed
  11. Decker D, et al. 2014. Lupus. 23:802. PubMed
  12. Jitschin R, et al. 2014. Blood. 123:2663. PubMed
  13. Anderson ME Jr, et al. 2014. Otolaryngol Head Neck Surg. 150:880. PubMed
  14. Giurisato E, et al. 2014. Mol Biol Cell. 25:1769. PubMed
  15. Shi J, et al. 2014. Blood. 123:4015. PubMed
  16. Kusner LL, et al. 2014. PLoS One. 9:102231. PubMed
  17. Fujisawa D, et al. 2014. J Allergy Clin Immunol. 134:622. PubMed
  18. Bhardwaj N, et al. 2014. J Virol. 88:11108. PubMed
  19. Lieber S, et al. 2014. Mol Pharmacol. 87:162. PubMed
  20. Olagnier D, et al. 2014. PLoS Pathog. 10:1004566. PubMed
  21. Punyadee N, et al. 2015. J Virol. 89:1587. PubMed
  22. Vuong TT, et al. 2015. J Histochem Cytochem. 63:280. PubMed
  23. Klingenberg R, et al. 2015. Eur Heart J. 36:1041. PubMed
  24. Wilkinson-Ryan I, et al. 2015. PLoS One.10:125851. PubMed
Product Citations
  1. Palacios-Arreola M, et al. 2017. Sci Rep. 10.1038/s41598-017-10135-1. PubMed
  2. Chen X, et al. 2019. Exp Ther Med. 1.265972222. PubMed
  3. Fisher RC, et al. 2019. Neoplasia. 1.061805556. PubMed
  4. Winkler CW, et al. 2019. J Neuroinflammation. 0.825694444. PubMed
  5. O'Huallachain M, et al. 2020. Commun Biol. 3:213. PubMed
  6. Argüello RJ, et al. 2020. Cell Metab. 32:1063. PubMed
  7. Aguilar EG, et al. 2021. Blood Adv. 5:4219. PubMed
  8. Lambert E, et al. 2022. Acta Neuropathol Commun. 10:4. PubMed
  9. Tocheva AS, et al. 2020. Curr Protoc Immunol. 130:e103. PubMed
  10. Ptacin JL, et al. 2021. Nat Commun. 12:4785. PubMed
  11. Lau D, et al. 2022. Nat Commun. 13:4053. PubMed
  12. Sipe CJ, et al. 2022. Int J Mol Sci. 23:. PubMed
  13. Alber S, et al. 2022. Front Immunol. 13:838636. PubMed
  14. Klingenberg R, et al. 2014. Eur Heart J. . PubMed
  15. Fujisawa D, et al. 2014. J Allergy Clin Immunol. 134:622. PubMed
  16. Simon A, et al. 2015. Blood. 126: 378 - 385. PubMed
  17. Mitton B, et al. 2016. Leukemia. 10.1038/leu.2016.139. PubMed
  18. Wanke F, et al. 2017. Cell Rep. 18(5):1270-1284. PubMed
  19. Ecker JW, et al. 2020. Vaccines (Basel). 8:00. PubMed
  20. Liu C, et al. 2021. Cell. 184(7):1836-1857.e22. PubMed
  21. Tsai AG, et al. 2020. Nat Med. 408:26. PubMed
  22. Starlard–Davenport A, et al. 2019. Br J Haematol. 186:91. PubMed
  23. Wartewig T, et al. 2017. Nature. . 10.1038/nature24649. PubMed
  24. Mehta P, et al. 2021. J Immunol. 207:1763. PubMed
  25. Lam B, et al. 2021. Cell Rep. 37:109838. PubMed
  26. de Cevins C, et al. 2021. Med (N Y). 2:1072. PubMed
  27. Gouin KH, et al. 2021. Nat Commun. 12:4906. PubMed
  28. Stanzione M, et al. 2022. Sci Adv. 8:eabn1229. PubMed
  29. Yoshida M, et al. 2022. Nature. 602:321. PubMed
  30. Egnuni T, et al. 2021. Pharmaceutics. 13:. PubMed
  31. Delvecchio FR, et al. 2021. Cell Mol Gastroenterol Hepatol. 12:1543. PubMed
  32. Jundi B, et al. 2021. JCI Insight. 6:e148866. PubMed
  33. Friebel E, et al. 2020. Cell. 181(7):1626-1642.e20. PubMed
  34. Ferrari de Andrade L, et al. 2020. Cancer Immunol Res. 0.867361111. PubMed
  35. Biasci D, et al. 2020. Proc Natl Acad Sci U S A. 117:28960. PubMed
  36. Glass DR, et al. 2020. Immunity. 53:217. PubMed
  37. Jackson S, et al. 2016. J Exp Med. 213: 733 - 750. PubMed
  38. Shin J, et al. 2016. Sci Rep. 6:23426. PubMed
  39. Vuong T, et al. 2015. J Histochem Cytochem. 63:280. PubMed
  40. Kusner L, et al. 2014. PLoS One. 9:102231. PubMed
  41. Raju R, et al. 2017. Stem Cells Dev. 26:274. PubMed
  42. Karagiannis TT, et al. 2020. Nat Commun. 2.271527778. PubMed
  43. Lee E, et al. 2021. Sci Rep. 11:14841. PubMed
  44. Doerflinger M, et al. 2021. Clin Transl Immunology. 10:e1235. PubMed
  45. Chen L, et al. 2021. Int J Mol Sci. 22:. PubMed
  46. Chen GM, et al. 2021. Cancer Discov. 11:2186. PubMed
  47. Kiritsy MC, et al. 2021. Elife. 10:. PubMed
  48. Rip J, et al. 2021. Bio Protoc. 11:e3902. PubMed
  49. Cluff E, et al. 2022. Cancer Immunol Immunother. . PubMed
  50. Mylka V, et al. 2022. Genome Biol. 23:55. PubMed
  51. Jairaman A, et al. 2022. Elife. 11:. PubMed
  52. Takano T, et al. 2022. Cell Rep Med. 3:100631. PubMed
  53. Vinjamur DS, et al. 2021. Nat Genet. 53:719. PubMed
  54. Judge SJ, et al. 2022. Front Immunol. 13:893177. PubMed
  55. Lo MW, et al. 2022. Clin Transl Immunology. 11:e1413. PubMed
  56. Masuda K, et al. 2022. JCI Insight. 7:. PubMed
  57. Patel T, et al. 2022. Aging Cell. 21:e13606. PubMed
  58. Trujillo G, et al. 2013. J Immunol. 191:848. PubMed
  59. Jimenez-Duran G, et al. 2020. EBioMedicine. 61:103039. PubMed
  60. Mogilenko DA, et al. 2020. Immunity. 54(1):99-115.e12. PubMed
  61. Nielsen CM, et al. 2021. Cell Reports Medicine. 2(3):100207. PubMed
  62. Goveia J, et al. 2020. Cancer Cell. 21:37. PubMed
  63. Feng WW, et al. 2019. Cell Rep. 29:3405. PubMed
  64. Li Z, et al. 2018. Exp Ther Med. 3.410416667. PubMed
  65. Mayer RL, et al. 2022. Nat Commun. 13:6075. PubMed
  66. Cook CP, et al. 2022. Cell Rep Med. 3:100715. PubMed
  67. Zhou WH, et al. 2022. Discov Oncol. 13:67. PubMed
  68. Wang M, et al. 2022. Immun Inflamm Dis. 10:e626. PubMed
  69. van der Heide V, et al. 2022. Cell Rep. :110508. PubMed
  70. Pérez-Pérez S, et al. 2022. Biomedicines. 10:. PubMed
  71. Figueroa-Romero C, et al. 2022. Front Immunol. 13:773288. PubMed
  72. Chen X, et al. 2022. Front Immunol. 12:807134. PubMed
  73. Emmons TR, et al. 2021. Cancer Immunol Res. 9:790. PubMed
  74. Snyder ME, et al. 2021. Am J Respir Crit Care Med. 203:1230. PubMed
  75. Klichinsky M, et al. 2020. Nat Biotechnol. 38:947. PubMed
  76. Gupta S, et al. 2020. Proc Natl Acad Sci U S A. 117:16481. PubMed
  77. AC Belkina, JE Snyder-Cappione 2017. Cytometry A. 91:175-179. PubMed
  78. Lindgren I, et al. 2016. Hum Reprod. 31: 672 - 683. PubMed
  79. Beljanski V, et al. 2015. J Virol. 89: 10612 - 10624. PubMed
  80. Pontarini E, et al. 2015. Rheumatology. 54: 1429-1434. PubMed
  81. Wright AKA, et al. 2017. J Allergy Clin Immunol. 140:1430. PubMed
  82. Al–Marsoummi S, et al. 2019. Cell Physiol Biochem. 53:999. PubMed
  83. Weisberg SP, et al. 2020. Cell Reports. 29(12):3916-3932.e5.. PubMed
  84. Seamon K, et al. 2020. Front Immunol. 11:396. PubMed
  85. Harris MJ, et al. 2021. Mol Syst Biol. 17:e10091. PubMed
  86. Liu C, et al. 2021. Cell Res. 31:1106. PubMed
  87. Pickering H, et al. 2021. JCI Insight. 6:. PubMed
  88. Nugent JL, et al. 2021. iScience. 24:103421. PubMed
  89. Chen Z, et al. 2022. J Nanobiotechnology. 20:30. PubMed
  90. Ogbe A, et al. 2022. JCI Insight. . PubMed
  91. Sun V, et al. 2021. Front Immunol. 12:716661. PubMed
  92. Andrews JM, et al. 2021. EBioMedicine. 71:103559. PubMed
  93. Apostolidis SA, et al. 2022. Front Immunol. 13:834988. PubMed
  94. Woodruff MC, et al. 2022. Nature. :. PubMed
  95. Wang L, et al. 2022. Theranostics. 12:7216. PubMed
  96. Jama B, Morris G 2014. J Vis Exp. 93: 52257. PubMed
  97. Patera A, et al. 2016. J Leukoc Biol. 100(6):1239-1254. PubMed
  98. Shi Z, et al. 2021. Ann Clin Transl Neurol. 8:43. PubMed
  99. Woodruff MC, et al. 2020. Nat Immunol. 1.920833333. PubMed
  100. Wang E, et al. 2021. Cell Stem Cell. 28(4):718-731.e6. PubMed
  101. Fuentes I, et al. 2020. Sci Rep. 10:15064. PubMed
  102. Stuart T, et al. 2019. Cell. 177:1888. PubMed
  103. Gao X, et al. 2017. PLoS One. 10.1371/journal.pone.0189167. PubMed
  104. Dashtsoodol N, et al. 2017. Front Immunol. 10.3389/fimmu.2017.01206. PubMed
  105. Deng H, et al. 2017. Arthritis Res Ther. 10.1186/s13075-017-1339-4. PubMed
  106. Kumar V, et al. 2022. Cells. 11:. PubMed
  107. Burnett CE, et al. 2022. Immunity. 55:1284. PubMed
  108. Calianese D, et al. 2021. J Immunol. 207:436. PubMed
  109. Ma YV, et al. 2021. MAbs. 13:2003281. PubMed
  110. Vijayakumar B, et al. 2022. Immunity. . PubMed
  111. Pérez-Pérez S, et al. 2021. Front Immunol. 12:798003. PubMed
  112. Chan JM, et al. 2021. Cancer Cell. 39:1479. PubMed
  113. Hendricks A, et al. 2021. Front Oncol. 11:646885. PubMed
  114. Toulmin SA, et al. 2021. Nat Commun. 12:3993. PubMed
  115. Stephenson E, et al. 2021. Nat Med. 27:904. PubMed
  116. Layer JV, et al. 2020. Proc Natl Acad Sci U S A. 27566:117. PubMed
  117. Dogra P, et al. 2020. Cell. 749:180. PubMed
  118. Zhang X, et al. 2020. J Immunol. 205:1743. PubMed
  119. Linke M, et al. 2017. Nat Immunol. 18:293-302. PubMed
  120. Ciarlo E, et al. 2016. Sci Rep. 6:37944. PubMed
  121. Vir P, et al. 2015. PLoS One. 10: 0144904. PubMed
  122. Zhang W, et al. 2019. Exp Ther Med. 2.490972222. PubMed
  123. Bocharnikov AV, et al. 2019. JCI Insight. 4:e126832. PubMed
  124. Mair F, et al. 2020. Cell Rep. 31:107499. PubMed
  125. Poonpanichakul T, et al. 2021. Front Immunol. 12:599805. PubMed
  126. Sen K, et al. 2021. Front Immunol. 12:733539. PubMed
  127. Zheng S, et al. 2022. Blood Cancer Discov. 3:103. PubMed
  128. Quinn TM, et al. 2022. EBioMedicine. 76:103856. PubMed
  129. Vanshylla K, et al. 2022. Cell Host Microbe. 30:69. PubMed
  130. Worwa G, et al. 2022. Commun Biol. 5:1204. PubMed
  131. Decker D, et al. 2014. Lupus. 123:2663. PubMed
  132. Lisovsky I, et al. 2015. J Virol. 89: 9909 - 9919. PubMed
  133. Busch S, et al. 2016. J Immunol. 197(11):4493-4503. PubMed
  134. Bowen J, et al. 2017. PLoS Pathog. 13(2):e1006164. PubMed
  135. Kreutmair S, et al. 2021. Immunity. . PubMed
  136. Rapiteanu R, et al. 2020. Eur Respir J. :55. PubMed
  137. Harrison TE, et al. 2020. Nature. 309:587. PubMed
  138. Maluski M, et al. 2019. J Clin Invest. 129:5108. PubMed
  139. Abrecht C, et al. 2022. STAR Protoc. 3:101362. PubMed
  140. Lai ZZ, et al. 2020. Am J Reprod Immunol. 84:e13295. PubMed
  141. Adamik J, et al. 2022. Nat Commun. 13:5184. PubMed
  142. Romine KA, et al. 2021. Blood Cancer Discov. 2:518. PubMed
  143. Vanuytsel K, et al. 2022. Nat Commun. 13:1103. PubMed
  144. Chakraborty S, et al. 2022. Sci Transl Med. . PubMed
  145. Muir LA, et al. 2022. JCI Insight. 7:. PubMed
  146. Romine KA, et al. 2021. Cancer Discov. . PubMed
  147. Rogers BM, et al. 2021. J Exp Med. 218:. PubMed
  148. Shen Z, et al. 2021. iScience. 24:103014. PubMed
  149. Wu CL, et al. 2021. Nat Commun. 12:362. PubMed
  150. Qiu XM, et al. 2020. Reproduction. 251:159. PubMed
  151. Gonzalez VD, et al. 2021. Cell Reports. 36(9):109632. PubMed
  152. Obradovic A, et al. 2021. Cell. 184(11):2988-3005.e16. PubMed
  153. Russ K, et al. 2021. Cell Reports. 34(12):108895. PubMed
  154. Marjanovic ND, et al. 2020. Cancer Cell. 38(2):229-246.e13. PubMed
  155. Judge SJ, et al. 2020. J Clin Invest. 130:3051. PubMed
  156. Market M, et al. 2020. Front Immunol. 1.127083333. PubMed
  157. Alshetaiwi H, et al. 2020. Sci Immunol. 5:00. PubMed
  158. Zhang S, et al. 2020. Front Immunol. 1.757638889. PubMed
  159. Jitschin R, et al. 2014. Blood. 123:2663. PubMed
  160. Souriant S, et al. 2019. Cell Rep. 26:3586. PubMed
  161. Riordon DR, et al. 2017. Methods Mol Biol. 1722:127. PubMed
  162. Cao Y, et al. 2021. Cell Res. 31:732. PubMed
  163. Wang W, et al. 2021. Clin Transl Med. 11:e253. PubMed
  164. Wang YC, et al. 2021. Nat Commun. 12:3530. PubMed
  165. Du Y, et al. 2022. Nat Commun. 13:231. PubMed
  166. Painter MM, et al. 2021. Immunity. 54:2133. PubMed
  167. Syrimi E, et al. 2021. iScience. 24:103215. PubMed
  168. Thijssen R, et al. 2022. Blood. :. PubMed
  169. Good Z, et al. 2022. Nat Med. :. PubMed
  170. Ferrer-Font L, et al. 2021. Curr Protoc. 1:e222. PubMed
  171. Weaver JD, et al. 2022. Oncoimmunology. 11:2141007. PubMed
  172. Edin S, et al. 2013. PLoS One. 18:74982. PubMed
  173. Borg Z, et al. 2014. J Immunol. 192:189. PubMed
  174. Shi J, et al. 2014. Blood. 123:4015. PubMed
  175. Galvani S, et al. 2015. Sci Signal. 8: ra79. PubMed
  176. Boyerinas B, et al. 2015. Cancer Immunol Res. 3: 1148 - 1157. PubMed
  177. Zabransky DJ, et al. 2015. Proc Natl Acad Sci U S A. 112: 6205 -6214. PubMed
  178. Thorek D, et al. 2016. Sci Transl Med. 8: 367ra167. PubMed
  179. Le BV, et al. 2020. Cell Rep. 33:108221. PubMed
  180. Venturutti L, et al. 2020. Cell. 182(2):297-316.e27. PubMed
  181. Lu Q, et al. 2021. Immunity. 54(6):1304-1319.e9. PubMed
  182. Zhang F, et al. 2020. EMBO Mol Med. e12034:12. PubMed
  183. Helmink BA, et al. 2020. Nature. 577:549. PubMed
  184. Yoon J, et al. 2020. Front Cell Dev Biol. 0.520138889. PubMed
  185. Poon E, et al. 2017. J Immunother Cancer. 10.1186/s40425-017-0268-8. PubMed
  186. Alvandi Z, et al. 2022. J Am Heart Assoc. 11:e023695. PubMed
  187. Chen Y, et al. 2022. Front Immunol. 13:835690. PubMed
  188. Zeng Q, et al. 2022. Front Immunol. 13:740805. PubMed
  189. Jiang Y, et al. 2020. Br J Pharmacol. . PubMed
  190. Opzoomer JW, et al. 2021. Elife. :10. PubMed
  191. Woodruff M, et al. 2020. medRxiv. . PubMed
  192. Nabet BY, et al. 2020. Cell. 183(2):363-376.e13. PubMed
  193. Zobel MJ, et al. 2020. J Immunother Cancer. 8:00. PubMed
  194. Seifert L, et al. 2015. Cell Rep. 13: 1909-1921. PubMed
  195. Punyadee N, et al. 2015. J Virol. 89:1587. PubMed
  196. Zhu Y, et al. 2019. Cell Stem Cell. 25:542. PubMed
  197. Chen G, et al. 2021. Signal Transduct Target Ther. 6:289. PubMed
  198. Besnier M, et al. 2021. Antioxidants (Basel). 10:. PubMed
  199. Dugger DT, et al. 2021. Front Immunol. 12:704172. PubMed
  200. Vick SC, et al. 2021. Sci Adv. 7:eabj0274. PubMed
  201. Hu Y, et al. 2021. Am J Hum Genet. 108:874. PubMed
  202. Levi H, et al. 2022. J Exp Med. 219:. PubMed
  203. Jorapur A, et al. 2022. PLoS Pathog. 18:e1010200. PubMed
  204. Trevelin SC, et al. 2022. Front Immunol. 13:838328. PubMed
  205. Sureshchandra S, et al. 2022. Cell Rep. 39:110938. PubMed
  206. Ndeupen S, et al. 2021. iScience. 24:103479. PubMed
  207. Zhu S, et al. 2022. J Oncol. 2022:8724933. PubMed
  208. Gadi D, et al. 2022. Leukemia. 36:723. PubMed
  209. Studniberg SI, et al. 2022. Mol Syst Biol. 18:e10824. PubMed
  210. Huang Y, et al. 2022. iScience. 25:105209. PubMed
  211. Quintanal-Villalonga A, et al. 2022. STAR Protoc. 3:101776. PubMed
  212. Liu Y, et al. 2022. Front Oncol. 12:1037934. PubMed
  213. Giurisato E, et al. 2014. Mol Biol Cell. 25:1769. PubMed
  214. Lundholm M, et al. 2015. Sci Rep. 5: 15651. PubMed
  215. Revelo X, et al. 2016. Cell Rep. 16: 717-730. PubMed
  216. Thomas K, et al. 2016. J Leukoc Biol. 100: 177 - 184. PubMed
  217. Burns JC, et al. 2020. eLife. 9:00. PubMed
  218. Herati RS, et al. 2021. Cell Reports Medicine. 2(5):100262. PubMed
  219. Ziegler CGK, et al. 2021. Cell. 184(18):4713-4733.e22. PubMed
  220. An Y, et al. 2021. Sci Rep. 6392:11. PubMed
  221. Cruz J, et al. 2011. J Immunol. 186:2282. PubMed
  222. Reustle A, et al. 2022. Clin Transl Med. 12:e883. PubMed
  223. Bahcecioglu G, et al. 2021. Adv Sci (Weinh). 8:e2100128. PubMed
  224. Li G, et al. 2021. Curr Protoc. 1:e50. PubMed
  225. Anadon CM, et al. 2022. STAR Protoc. 3:101649. PubMed
  226. Nadeu F, et al. 2022. Nat Med. 28:1662. PubMed
  227. Hirschberger S, et al. 2022. Front Med (Lausanne). 9:923502. PubMed
  228. Pathania AS, et al. 2022. Mol Ther Oncolytics. 25:308. PubMed
  229. Wang J, et al. 2022. iScience. 25:103971. PubMed
  230. Wu Y, et al. 2022. J Cancer Res Clin Oncol. . PubMed
  231. Woolley CR, et al. 2022. Immunohorizons. 6:47. PubMed
  232. Wendisch D, et al. 2021. Cell. 184:6243. PubMed
  233. Chen DL, et al. 2021. Mol Cancer. 20:166. PubMed
  234. Poon MML, et al. 2021. Cell Rep. 37:110071. PubMed
  235. Henrich IC, et al. 2021. Cancer Res. 81:2171. PubMed
  236. Wegner J, et al. 2021. Sci Rep. 11:14983. PubMed
  237. Sun L, et al. 2021. Sci Rep. 11:12477. PubMed
  238. Li H, et al. 2021. Adv Sci (Weinh). 2001596:8. PubMed
  239. OConnor RA, et al. 2021. OncoImmunology. 10(1):1940675. PubMed
  240. Cheng Y, et al. 2021. Immunity. 54(8):1825-1840.e7. PubMed
  241. Glassman CR, et al. 2021. Cell. 184(4):983-999.e24. PubMed
  242. Zeng J, et al. 2020. Nat Med. 26:535. PubMed
  243. Wang C, et al. 2015. Clin Immunol. 159: 47-57. PubMed
  244. Luo L, et al. 2011. Exp Mol Pathol. 91:596. PubMed
  245. Qin XH, et al. 2019. Langmuir. 35:1882. PubMed
  246. Song M, et al. 2018. Nature. 562:423. PubMed
  247. Good Z, et al. 2019. Nat Biotechnol. 37:259. PubMed
  248. Xue J, et al. 2020. Arthritis Res Ther. 1.070138889. PubMed
  249. Li YR, et al. 2021. Cell Rep Med. 2:100449. PubMed
  250. Mudd PA, et al. 2022. Cell. 185:603. PubMed
  251. Kusi M, et al. 2022. Cell Rep. 38:110220. PubMed
  252. Dahal S, et al. 2022. Retrovirology. 19:18. PubMed
  253. Cortés-López M, et al. 2022. Nat Commun. 13:5570. PubMed
  254. LaSalle TJ, et al. 2022. Cell Rep Med. 3:100779. PubMed
  255. Tsuboki J, et al. 2016. Sci Rep. 6:29588. PubMed
  256. Gao M, et al. 2016. Sci Rep. 6:29955. PubMed
  257. Stephanie Elizabeth, Johanna Zandee 2017. Immunol Cell Biol. 10.1038/icb.2017.3. PubMed
  258. Morales Pantoja IE, et al. 2020. PLoS One. 15:e0233980. PubMed
  259. Huetter J, et al. 2020. Cancer Immunol Res. 0.954861111. PubMed
  260. Still C 2nd, et al. 2021. Cell Reports Medicine. 2(7):100343. PubMed
  261. Feng W, et al. 2020. J Vis Exp. . PubMed
  262. Hannon E, et al. 2021. PLoS Genet. e1009443:17. PubMed
  263. Ellyard JI, et al. 2019. Front Immunol. 1.898611111. PubMed
  264. Fan C, et al. 2019. Mol Med Rep. 3.002083333. PubMed
  265. Franco LM, et al. 2019. J Exp Med. 216:384. PubMed
  266. Oetjen KA, et al. 2018. JCI Insight. 3:e124928. PubMed
  267. Jiang X, et al. 2018. Cell Mol Immunol. 1.338194444. PubMed
  268. Gov L,et al. 2017. J Immunol. 10.4049/jimmunol.1700245. PubMed
  269. Metcalf T, et al. 2017. J Immunol. 10.4049/jimmunol.1700148. PubMed
  270. Huang D, et al. 2022. Cell Discov. 8:121. PubMed
  271. Shemesh A, et al. 2022. J Exp Med. 219:. PubMed
  272. Michelozzi IM, et al. 2022. STAR Protoc. 3:101174. PubMed
  273. Lo YC, et al. 2022. Nat Commun. 13:934. PubMed
  274. Thakkar D, et al. 2022. J Immunother Cancer. 10:. PubMed
  275. Erickson JR, et al. 2022. Proc Natl Acad Sci U S A. 119:. PubMed
  276. Wang X, et al. 2022. J Immunol. 208:396. PubMed
  277. Fang F, et al. 2021. Cell Rep. 37:109981. PubMed
  278. Paul S, et al. 2021. Sci Transl Med. 13:. PubMed
  279. Combes AJ, et al. 2021. Nature. 591:124. PubMed
  280. Larson-Casey JL, et al. 2020. PLoS One. 15:e0241323. PubMed
  281. Carmona-Rivera C, et al. 2020. JCI Insight. 5:00. PubMed
  282. Surendran N, et al. 2016. Innate Immunity. 22: 63 - 71. PubMed
  283. Lines J, et al. 2014. Cancer Res. 74:1924. PubMed
  284. Alves V, et al. 2013. Infect Immun . 81:4399. PubMed
  285. Guo JJ, et al. 2017. Exp Ther Med. 3.842361111. PubMed
  286. Zhao Y, et al. 2020. Immunity. 51(6):1059-1073.e9.. PubMed
  287. Nobre LV, et al. 2020. eLife. 8:e49894.. PubMed
  288. Hoffmann J, et al. 2021. Nat Commun. 12:3964. PubMed
  289. Zhang X, et al. 2021. Nat Commun. 12:4536. PubMed
  290. Hirschberger S, et al. 2021. EMBO Mol Med. 13:e14323. PubMed
  291. Liao M, et al. 2021. Aging (Albany NY). 13:22412. PubMed
  292. Gutierrez C, et al. 2021. Nat Cancer. 2:758. PubMed
  293. Georg P, et al. 2022. Cell. 185:493. PubMed
  294. Céspedes PF, et al. 2022. Nat Commun. 13:3460. PubMed
  295. Zhang F, et al. 2021. Genome Med. 13:64. PubMed
  296. Luque-Martin R, et al. 2021. J Immunol. 207:555. PubMed
  297. Li F, et al. 2022. Nat Commun. 13:4334. PubMed
  298. Rydyznski Moderbacher C, et al. 2022. J Clin Invest. :. PubMed
  299. Hwang B, et al. 2021. Nat Methods. 18:903. PubMed
  300. Montel-Hagen A, et al. 2022. Curr Protoc. 2:e403. PubMed
  301. López-Sanz C, et al. 2022. STAR Protoc. 3:101755. PubMed
  302. Szerlip N, et al. 2012. Proc Natl Acad Sci U S A. 109:3041. PubMed
  303. Bromley S, et al. 2013. J Immunol. 190:970. PubMed
  304. Lieber S, et al. 2014. Mol Pharmacol. 87:162. PubMed
  305. Page K, et al. 2015. J Pharmacol Exp Ther. 355: 199 - 205. PubMed
  306. Wanke-Jellinek L, et al. 2016. J Immunol. 196: 767 - 777. PubMed
  307. Schneeberger V, et al. 2016. PLoS One. 11: 0160587. PubMed
  308. Maini A, et al. 2016. PLoS One. 11:e0165502. PubMed
  309. Burel J, et al. 2016. PLoS Negl Trop Dis. 10:e0005031. PubMed
  310. Kirabo A, et al. 2017. J Mol Cell Cardiol. 10.1016/j.yjmcc.2017.03.001. PubMed
  311. Judge SJ, et al. 2020. J Immunother Cancer. 8:00. PubMed
  312. Greenlee JD, et al. 2021. eLife. 0.416666666666667. PubMed
  313. Herland A, et al. 2020. Nat Biomed Eng. 421:4. PubMed
  314. Hepprich M, et al. 2020. Cell Metab. 699:31. PubMed
  315. Demaree B, et al. 2021. Nat Commun. 1583:12. PubMed
  316. Wierzbinska JA, et al. 2020. Genome Med. 12:29. PubMed
  317. Bricio–Moreno L, et al. 2018. Nat Commun. 2.204861111. PubMed
  318. Arrigucci R, et al. 2017. Nat Protoc. 1.364583333. PubMed
  319. Strazza M, et al. 2022. Mol Ther Methods Clin Dev. 27:380. PubMed
  320. Konkimalla A, et al. 2022. iScience. 25:105114. PubMed
  321. Tang JS, et al. 2022. Front Immunol. 13:946713. PubMed
  322. Liu Y, et al. 2022. Clin Transl Med. 12:e654. PubMed
  323. Ruan LY, et al. 2022. Biomolecules. 12:. PubMed
  324. Lederer K, et al. 2022. Cell. . PubMed
  325. Wang YM, et al. 2022. Oncoimmunology. 11:2034257. PubMed
  326. Jiang J, et al. 2021. Front Immunol. 12:785549. PubMed
  327. Yang Y, et al. 2021. Emerg Microbes Infect. 10:905. PubMed
  328. Shuwa HA, et al. 2021. Med. 2(6):720-735.e4. PubMed
  329. Landgraf KE, et al. 2020. Commun Biol. 0.330555556. PubMed
  330. Nahid M, et al. 2016. J Leukoc Biol. 100: 339 - 349. PubMed
  331. Eichten A, et al. 2016. Cancer Res . 76: 2327-2339. PubMed
  332. Sade–Feldman M, et al. 2018. Cell. 175:998. PubMed
  333. Kubala MH, et al. 2018. Cell Rep. 25:2177. PubMed
  334. Wu X, et al. 2020. Front Immunol. 1.922222222. PubMed
  335. Wang YJ, et al. 2021. Sci Rep. 11:8054. PubMed
  336. Rovira-Clavé X, et al. 2021. Nat Commun. 12:4628. PubMed
  337. Wurm M, et al. 2021. Mol Cancer Ther. 20:2250. PubMed
  338. Pauken CM, et al. 2021. Cancers (Basel). 13:. PubMed
  339. Genge PC, et al. 2021. STAR Protoc. 2:100900. PubMed
  340. Winkler C, et al. 2021. JCI Insight. 6:. PubMed
  341. Adamo S, et al. 2022. Nature. 602:148. PubMed
  342. Krijgsman D, et al. 2022. STAR Protoc. 3:101034. PubMed
  343. Hallisey M, et al. 2022. STAR Protoc. 3:101163. PubMed
  344. Konishi S, et al. 2022. STAR Protoc. 3:101447. PubMed
  345. Galván-Peña S, et al. 2021. Proc Natl Acad Sci U S A. 118:. PubMed
  346. Wilson TL, et al. 2022. Cancer Discov. 12:2098. PubMed
  347. Claireaux MAF, et al. 2022. Nat Commun. 13:4539. PubMed
  348. Allard-Chamard H, et al. 2021. J Immunol. 206:524. PubMed
  349. Maas RR, et al. 2021. Nat Protoc. 16:4692. PubMed
  350. Mujal AM, et al. 2022. Cancer Immunol Res. 10:403. PubMed
  351. Delgado-Gonzalez A, et al. 2022. STAR Protoc. 3:101425. PubMed
  352. Chou DB, et al. 2022. Nat Commun. 13:6021. PubMed
  353. Bhardwaj N, et al. 2014. J Virol. 88:11108. PubMed
  354. Olagnier D, et al. 2014. PLoS Pathog. 10:1004566. PubMed
  355. Wilkinson-Ryan I, et al. 2015. PLoS One. 10:125851. PubMed
  356. Ali A, et al. 2015. PLoS One. 10: 0131645. PubMed
  357. Kanzaki H, et al. 2016. Sci Rep. 6:32259. PubMed
  358. Goehring K, et al. 2016. J Nutr. 146(12):2559-2566. PubMed
  359. Festag J, et al. 2020. Mol Ther Nucleic Acids. 1.330555556. PubMed
  360. Maehara T, et al. 2020. J Clin Invest. 130:2451. PubMed
  361. Mathewson ND, et al. 2021. Cell. 184(5):1281-1298.e26. PubMed
  362. Szodoray P, et al. 2021. Cell Reports. 36(6):109525. PubMed
  363. Jin HS, et al. 2020. Cancer Immunol Res. 8:912. PubMed
  364. Sontheimer-Phelps A, et al. 2019. Cell Mol Gastroenterol Hepatol. 9:507. PubMed
  365. Han P, et al. 2020. Sci Adv. 6:eaaz1580. PubMed
  366. Cai Q, et al. 2019. Oncol Lett. 2.967361111. PubMed
  367. Yang ZZ, et al. 2019. Cell Rep. 26:2178. PubMed
  368. Olafsdottir TA, et al. 2022. Commun Biol. 5:914. PubMed
  369. Lau P, et al. 2022. Cell Mol Immunol. :. PubMed
  370. Alhussan A, et al. 2022. Cancers (Basel). 14:. PubMed
  371. Lee PC, et al. 2022. J Clin Invest. 132:. PubMed
  372. Rouhani SJ, et al. 2022. J Immunother Cancer. 10:. PubMed
  373. Chan M, et al. 2021. Mol Syst Biol. 17:e10426. PubMed
  374. Rodríguez-Lorenzo S, et al. 2022. Elife. 11:. PubMed
  375. Vechetti IJ, et al. 2021. FASEB J. 35:e21644. PubMed
  376. Manríquez V, et al. 2021. Nat Commun. 12:4547. PubMed
  377. Tomita T, et al. 2021. Nat Commun. 12:3655. PubMed
  378. Salahudeen AA, et al. 2020. bioRxiv. . PubMed
  379. Qi J, et al. 2021. Cell Reports Medicine. 2(8):100353. PubMed
  380. Hara T, et al. 2021. Cancer Cell. 39(6):779-792.e11. PubMed
  381. Clayton KL, et al. 2021. Cell Host Microbe. 29(3):435-447.e9. PubMed
  382. Nielsen S, et al. 2016. Nat Cell Biol. 18: 549-560. PubMed
  383. Jarantow S, et al. 2015. J Biol Chem. 290: 24689 - 24704. PubMed
  384. Anderson M, et al. 2014. Otolaryngology Head Neck Surg. 150:880. PubMed
  385. Lynskey N, et al. 2017. PLoS Pathog.. 10.1371/journal.ppat.1006493. PubMed
  386. Eitas T, et al. 2017. PLoS One. 10.1371/journal.pone.0184164. PubMed
  387. Verma SK, et al. 2018. J Biol Chem. 293:254. PubMed
  388. Shaw BC, et al. 2021. CRISPR J. 4:699. PubMed
  389. Chen C, et al. 2022. iScience. 25:103645. PubMed
  390. Lu J, et al. 2022. STAR Protoc. 3:101559. PubMed
  391. Ainsworth RI, et al. 2022. Nat Commun. 13:6221. PubMed
  392. Pleguezuelos O, et al. 2015. Clin Vaccine Immunol. 22: 828 - 835. PubMed
  393. Alasoo K, et al. 2015. Sci Rep. 5: 12524. PubMed
  394. Burel J, et al. 2016. PLoS Pathog. 12: 1005839. PubMed
  395. MacBride M, et al. 2017. Mammalian Genome. 10.1007/s00335-017-9680-0. PubMed
  396. Chou DB, et al. 2020. Nat Biomed Eng. 0.440277778. PubMed
  397. Nistler R, et al. 2020. Immunohorizons. 0.397222222. PubMed
  398. Pettmann J, et al. 2021. eLife. 10:00. PubMed
  399. Luoma AM, et al. 2020. Cell. 182(3):655-671.e22. PubMed
  400. Perugino CA, et al. 2021. J Allergy Clin Immunol. 368:147. PubMed
  401. Binnewies M, et al. 2019. Cell. 177:556. PubMed
  402. Nightingale K, et al. 2018. Cell Host Microbe. 24:447. PubMed
  403. Itoh H, et al. 2017. J Vet Med. 10.1155/2017/5701016. PubMed
  404. Kamada R, et al. 2017. The Journal of Biochemistry. 10.1093/jb/mvx032. PubMed
  405. Yao W, et al. 2017. Molecular Immunology. 10.1016/j.molimm.2017.04.017. PubMed
  406. Jeong HO, et al. 2022. iScience. 25:105358. PubMed
  407. Murphy DM, et al. 2022. J Clin Invest. Online ahead of print. PubMed
  408. Faissner S, et al. 2022. Front Immunol. 13:980526. PubMed
  409. Zha Y, et al. 2022. Front Immunol. 13:877314. PubMed
  410. Wang H, et al. 2022. J Cancer. 13:2126. PubMed
  411. Medeiros-Furquim T, et al. 2022. Front Immunol. 13:678817. PubMed
  412. Kaya-Tilki E, et al. 2021. PLoS One. 16:e0260633. PubMed
  413. Kämpe A, et al. 2021. PLoS One. 16:e0257442. PubMed
  414. Pinto SM, et al. 2021. Front Immunol. 12:679458. PubMed
  415. Chiou SH, et al. 2021. Immunity. 54:586. PubMed
  416. Wang EY, et al. 2021. Nature. 595:283. PubMed
  417. Mpakou V, et al. 2021. Exp Ther Med. 1.010416667. PubMed
  418. Scharenberg SG, et al. 2020. Nat Commun. 2.76875. PubMed
  419. Sainson RCA, et al. 2020. Cancer Immunol Res. 1.422222222. PubMed
  420. Salahudeen AA, et al. 2020. Nature. 588:670. PubMed
  421. Okamura Y, et al. 2017. Allergol Int. 10.1016/j.alit.2017.03.002. PubMed
  422. An L, et al. 2016. Sci Rep. 6: 33346. PubMed
  423. Wolf J, et al. 2016. J Biol Chem. 291: 16186 - 16196. PubMed
  424. Schneck H, et al. 2015. PLoS One. 10: 0144535. PubMed
RRID
AB_2818986 (BioLegend Cat. No. 422302)

Antigen Details

Molecular Family
Fc Receptors
Gene ID
NA

Related FAQs

Is our human Trustain FcX™ (cat# 422302) compatible with anti human CD16, CD32 and CD64 clones 3G8, FUN-2 and 10.1 respectively?

Yes

What is the concentration of Human TruStain FcX™ (Fc receptor blocking solution, Cat#422301)?
This information is proprietary.
Go To Top Version: 4    Revision Date: 07/14/2016

For Research Use Only. Not for diagnostic or therapeutic use.

 

This product is supplied subject to the terms and conditions, including the limited license, located at www.biolegend.com/terms) ("Terms") and may be used only as provided in the Terms. Without limiting the foregoing, BioLegend products may not be used for any Commercial Purpose as defined in the Terms, resold in any form, used in manufacturing, or reverse engineered, sequenced, or otherwise studied or used to learn its design or composition without express written approval of BioLegend. Regardless of the information given in this document, user is solely responsible for determining any license requirements necessary for user’s intended use and assumes all risk and liability arising from use of the product. BioLegend is not responsible for patent infringement or any other risks or liabilities whatsoever resulting from the use of its products.

 

BioLegend, the BioLegend logo, and all other trademarks are property of BioLegend, Inc. or their respective owners, and all rights are reserved.

 

8999 BioLegend Way, San Diego, CA 92121 www.biolegend.com
Toll-Free Phone: 1-877-Bio-Legend (246-5343) Phone: (858) 768-5800 Fax: (877) 455-9587

ProductsHere
Login / Register
Remember me
Forgot your password? Reset password?
Create an Account